Differences in pili structure modulate bacterial behavior
Type IV pili, or T4P, are hairlike protein appendages on the surface of bacteria that can retract to assist in movement and DNA uptake or resist retraction to promote adhesion and bacterial aggregation. Strains of Acinetobacter bacteria show differences in the balance of these T4P-dependent behaviors, but it is unclear why these differences occur.
Yafan Yu and colleagues from the University of Georgia and the University of Nebraska–Lincoln published a study in the Journal of Biological Chemistry demonstrating how differences in pilus structure affect bacterial behavior. Researchers compared two Acinetobacter strains, International Clone I, or IC-I, and International Clone II, or IC-II, which differ in the sequence of PilA, the main subunit and building block of T4P. For direct comparison of pilus structure and function, they created genetically identical strains by replacing the native PilA gene with IC-I or IC-II variants. They found that IC-I PilA formed pili with efficient retraction behavior, promoting motility and DNA uptake. In contrast, the IC-II PilA produced pili that resisted retraction, leading to increased surface pili and biofilm formation.
These results illustrate that small changes in pilus structure can affect bacterial behavior, demonstrating how similar bacterial strains adapt to different environments. Future research can investigate how targeting the T4P structure to control pilus retraction and adhesion can open new avenues for complementary, targeted antibacterial therapeutics.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.